Literature DB >> 1443049

The genesis of the senile plaque. Further evidence in support of its neuronal origin.

M A Pappolla1, R A Omar, K Sambamurti, J P Anderson, N K Robakis.   

Abstract

Senile plaques are among the most conspicuous neuropathologic changes found in the brains of elderly individuals and patients with Alzheimer's disease (AD). The origin of the amyloid beta protein (A beta P) that accumulates in senile plaques continues to be highly controversial. Recently, using quantitative immunohistochemistry and computerized image analysis, we obtained evidence that at least a subset of early ("diffuse") senile plaques originate from neurons. In the current investigation, we employed monoclonal antibodies to A beta P and the same computerized methodology to examine in further detail the quantitative patterns of A beta P deposition in diffuse plaques in a population of intellectually intact elderly individuals. The presence of neurocentric concentration gradients of A beta P accumulation was confirmed in this study. Most significantly, this was the most predominant pattern of early amyloid deposition in the population studied. The highest concentration of A beta P was centered around neuronal cell bodies or their processes, and occasionally along neuronal plasma membranes. Computerized images showed patterns that can be interpreted as a pathogenetic sequence ranging from initial neurogenic concentration gradients centered around one single neuron to larger deposits (diffuse plaques) composed of several "anastomosing" gradients involving several adjacent neurons. It is proposed that the described very early deposits constitute the initial stage in the development of the senile plaque. Although this study does not fully prove that the accumulated A beta P is synthesized in the neuron or neuronal process it surrounds, the images herein presented suggest that neurons are the initial nidus of plaque formation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443049      PMCID: PMC1886669     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

2.  Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody.

Authors:  S Ikeda; D Allsop; G G Glenner
Journal:  Lab Invest       Date:  1989-01       Impact factor: 5.662

3.  The "normal" brain. "Abnormal" ubiquitinilated deposits highlight an age-related protein change.

Authors:  M A Pappolla; R Omar; B Saran
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

4.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease.

Authors:  B A Yankner; L R Dawes; S Fisher; L Villa-Komaroff; M L Oster-Granite; R L Neve
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

5.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Immunohistological study of senile brains by using a monoclonal antibody recognizing beta amyloid precursor protein: significance of granular deposits in relation with senile plaques.

Authors:  H Takahashi; C Kurashima; M Utsuyama; K Hirokawa
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-08-16       Impact factor: 3.575

8.  Sulfated glycosaminoglycans in amyloid plaques of prion diseases.

Authors:  A D Snow; R Kisilevsky; J Willmer; S B Prusiner; S J DeArmond
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques.

Authors:  G Giaccone; F Tagliavini; G Linoli; C Bouras; L Frigerio; B Frangione; O Bugiani
Journal:  Neurosci Lett       Date:  1989-02-13       Impact factor: 3.046

10.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus.

Authors:  R E Tanzi; J F Gusella; P C Watkins; G A Bruns; P St George-Hyslop; M L Van Keuren; D Patterson; S Pagan; D M Kurnit; R L Neve
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  4 in total

1.  Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain.

Authors:  M Morishima-Kawashima; N Oshima; H Ogata; H Yamaguchi; M Yoshimura; S Sugihara; Y Ihara
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease.

Authors:  Robert J Baranello; Krishna L Bharani; Vasudevaraju Padmaraju; Nipun Chopra; Debomoy K Lahiri; Nigel H Greig; Miguel A Pappolla; Kumar Sambamurti
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

3.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

Authors:  M A Pappolla; Y J Chyan; R A Omar; K Hsiao; G Perry; M A Smith; P Bozner
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

4.  Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.

Authors:  M L Schmidt; K A Robinson; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.